Search PDMR transactions

Notifier
Name
Johan Frostegård
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Anna Frostegård
Position
Chief Scientific and Medical Officer
Initial notification
No
Amendment
Yes
Details of amendment
uppdaterat ISIN, aktier tecknades via bolag, Medirista AB och Frostskog AB
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name
Annexin Pharmaceuticals
LEI
5493000JP703HGPJEX27
Details of transaction
Type of financial instrument Name ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA Annexin Pharmaceuticals SE0013748894 Subscription 1,404,972 Quantity 1.15 SEK 26/02/2020 Outside a trading venue
Aggregation
Name ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Annexin Pharmaceuticals SE0013748894 Subscription 26/02/2020 Outside a trading venue 1,404,972 (Quantity) 1.15 SEK
Total: 1,404,972
<< Back